George O Tora

This inventor holds 23 USPTO granted patents and 1 published patent application and 11 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bristol-Myers Squibb Compnay, Bristol Meyers Squibb Company. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George O Tora. Retrieved from https://idiyas.com/inventor/george-o-tora

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 8.2

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

Meriden, CT (US) (2007 - 2010)
Langhorne, NJ (US) (2015)
Langhorne, PA (US) (2011 - 2023)

Company Filing History:

21 out of 3,745

Bristol-Myers Squibb Compnay

patents

2 out of 41

Bristol Meyers Squibb Company

patents

Years Active: 2007-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Amides

APJ Receptor Agonists

Endothelial Lipase Inhibitors

CNS Disorders

Anti-Migraine Treatments

Benzothiazole Inhibitors

Sulfonyl Compounds

Pyrrolinone Carboxamides

Serotonin Transporter Inhibitors

Calcitonin Gene Related Peptide

Spirocycles

4-Hydroxy Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758559 - RXFP1 agonists (2026-10-13),

2. 11673886 - 5-membered and bicyclic heterocyclic amides as inhibitors of ROCK (2023-06-13),

3. 11078197 - 5-membered and bicyclic heterocyclic amides as inhibitors of rock (2021-08-03),

4. 10889565 - 4-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists (2021-01-12),

5. 10590113 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2020-03-17),

6. 10508104 - 6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists (2019-12-17),

7. 10392347 - 2,4-dihydroxy-nicotinamides as APJ agonists (2019-08-27),

8. 10106528 - 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists (2018-10-23),

9. 9540323 - [object Object] (2017-01-10),

10. 9493412 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors (2016-11-15),

11. 9169240 - Ketone linked benzothiazole inhibitors of endothelial lipase (2015-10-27),

12. 9139578 - Amide or urea containing benzothiazole inhibitors of endothelial lipase (2015-09-22),

13. 9120794 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors (2015-09-01),

14. 8987314 - Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase (2015-03-24),

15. 8952180 - Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors (2015-02-10),

Title: The Innovative Mind of George O Tora

Introduction: George O Tora, a brilliant inventor hailing from Langhorne, PA, is a woman who has made significant contributions to the world of technology and innovation.

Latest Patents: George O Tora's latest patents include groundbreaking inventions in the field of renewable energy storage systems and advanced medical devices.

Career Highlights: Throughout her illustrious career, George O Tora has been recognized for her pioneering work in developing cutting-edge solutions for environmental sustainability and healthcare advancements. Her innovative spirit has led to the creation of numerous patented technologies that have revolutionized their respective industries.

Collaborations: George O Tora has collaborated with leading research institutions, universities, and companies to bring her inventions to life. Her partnerships have been instrumental in turning her visionary ideas into tangible products that have had a lasting impact on society.

Conclusion: George O Tora's passion for innovation and her dedication to pushing the boundaries of what is possible make her a true trailblazer in the world of inventors. Her work continues to inspire future generations to think creatively and strive for excellence in their pursuits.

Profile summary based on public USPTO records.